639
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature

, , , , , & show all
Pages 820-829 | Received 19 Jul 2011, Accepted 10 Oct 2011, Published online: 13 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Caroline Dartigeas, Eric Van Den Neste, Christian Berthou, Hervé Maisonneuve, Stéphane Leprêtre, Marie-Sarah Dilhuydy, Marie-Christine Béné, Florence Nguyen-Khac, Rémi Letestu, Florence Cymbalista, Sophie De Guibert, Thérèse Aurran, Kamel Laribi, Jean-Pierre Vilque, Olivier Tournilhac, Alain Delmer, Pierre Feugier, Bruno Cazin, Anne-Sophie Michallet, Vincent Lévy, Xavier Troussard, Roselyne Delepine, Elsa Tavernier, Philippe Colombat & Véronique Leblond. (2016) Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 57:2, pages 328-334.
Read now

Articles from other publishers (3)

Eric Durot, Anne-Sophie Michallet, Stéphane Leprêtre, Quoc-Hung Le, Véronique Leblond & Alain Delmer. (2015) Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study. European Journal of Haematology 95:2, pages 160-167.
Crossref
J. Hibler, Andrea L. Salavaggione, Ann Martin & Alejandro A. Gru. (2015) A unique case of concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and lymphomatoid papulosis in the same biopsy. Journal of Cutaneous Pathology 42:4, pages 276-284.
Crossref
Claire Fabre, Marco Gobbi, Cyrine Ezzili, Mustapha Zoubir, Marie-Paule Sablin, Karen Small, Ellie Im, Nabeegha Shinwari, Da Zhang, Honghong Zhou & Christophe Le Tourneau. (2014) Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients. Cancer Chemotherapy and Pharmacology 74:5, pages 1057-1064.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.